Christina Cameron
Investor Relations Contact bij ANTIBE THERAPEUTICS INC.
Profiel
Christina Cameron is currently working as the Director-Investor Relations at Medicago, Inc. and as the Vice President-Investor Relations at Antibe Therapeutics, Inc. She completed her undergraduate degree from Wilfrid Laurier University.
Actieve functies van Christina Cameron
Bedrijven | Functie | Begin |
---|---|---|
ANTIBE THERAPEUTICS INC. | Investor Relations Contact | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Investor Relations Contact | - |
Opleiding van Christina Cameron
Wilfrid Laurier University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ANTIBE THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |